Carvolix (XPAR:CVX) Marketable Securities: €0.02 Mil (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:CVX Carvolix SA XPAR:CVX
30 GF Score
Price €6.32
! 3 Warning Signs
View Full Analysis

What is Carvolix Marketable Securities?

Carvolix XPAR:CVX +6.40% 30 Marketable Securities is €0.02 Mil as of Jun. 2025. GuruFocus rates XPAR:CVX with a GF Score™ of 30/100. The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Carvolix's Marketable Securities for the quarter that ended in Jun. 2025 was €0.02 Mil.

Carvolix's annual Marketable Securities stayed the same from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€0.00 Mil) but then increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€5.39 Mil).


Carvolix  (XPAR:CVX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Carvolix Marketable Securities Related Terms


Carvolix Marketable Securities Historical Data

* Premium members only.

The historical data trend for Carvolix's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carvolix Marketable Securities Chart

Carvolix Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 5.39 0.00

Carvolix Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 5.39 0.02 0.00
XPAR:CVX
30GF Score
Carvolix SA XPAR:CVX
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carvolix Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.02 Mil mean?
Carvolix (XPAR:CVX) has a Marketable Securities of €0.02 Mil as of Jun. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Carvolix and its competitors.
Is Carvolix's Marketable Securities too high?
Carvolix's current Marketable Securities is €0.02 Mil. Overall, Carvolix has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Carvolix's Marketable Securities compare to ABT and SYK?
Carvolix's Marketable Securities of €0.02 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Carvolix and its competitors. Carvolix's current Marketable Securities is €0.02 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carvolix stock overvalued right now?
Carvolix (XPAR:CVX) has a current Marketable Securities of €0.02 Mil. The current Marketable Securities is €0.02 Mil. Carvolix's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Carvolix (XPAR:CVX), the current Marketable Securities is €0.02 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Carvolix Business Description

Other Exchanges 0JZ:Germany
Address 320 Avenue Archimede, Les Pleiades III - Batiment B, Aix-en-Provence, FRA, 13100
Carvolix SA specializes in the development of AI-based mini-robots and biomimetic implants designed to autonomously replace heart valves and treat strokes.
30GF Score

Get the complete analysis for XPAR:CVX

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.32
Price